1. P1429: MULTIPLEX DELETION OF MYELOID ANTIGENS CD33 AND CLL-1 BY CRISPR/CAS9 IN HUMAN HEMATOPOIETIC STEM CELLS HIGHLIGHTS THE POTENTIAL OF NEXT-GENERATION TRANSPLANTS FOR AML TREATMENT. (23rd June 2022) Authors: Xavier-Ferrucio, J.; Luo, C.; Angelini, G.; Krishnamurthy, S.; Patel, N.; Pettiglio, M.; Collingsworth, T.; Isik, M.; Ghodssi, A.; Halfond, A.; Etchin, J.; Keschner, Y.; Mundelboim, G.; Tavares, P.; Cummins, C.; Falla, A.; Hazelbaker, D.; Paik, E.; Sanchez, J.; Ge, G. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1312 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗